Fixed Dose Rate Infusion of Gemcitabine with Oral Doxifluridine and Leucovorin for Advanced Unresectable Pancreatic Cancer: A Phase II Study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Fixed Dose Rate Infusion of Gemcitabine with Oral Doxifluridine and Leucovorin for Advanced Unresectable Pancreatic Cancer: A Phase II Study

Published:2007-12-10 Issue:1 Volume:54 Page:54-62
ISSN:0009-3157
Container-title:Chemotherapy
language:en
Short-container-title:Chemotherapy

Author:

Kim Hawk,Park Jae-Hoo,Shin Su Jin,Kim Mee-Ja,Bang Sung-Jo,Park Neung Hwa,Nah Yang Won,Nam Chang Woo,Joo Kwang Ro,Min Young Joo

Publisher

S. Karger AG

Subject

Infectious Diseases,Pharmacology (medical),Drug Discovery,Pharmacology,Oncology,General Medicine

Reference31 articles.

1. Cancer statistics, 1997

2. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.

3. Phase III Study of Gemcitabine in Combination With Fluorouracil Versus Gemcitabine Alone in Patients With Advanced Pancreatic Carcinoma: Eastern Cooperative Oncology Group Trial E2297

4. A combination of a fixed dose rate infusion of gemcitabine associated to a bolus 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of Phase II Trial Design in Advanced Pancreatic Cancer;Pancreas;2019-11

2. Novel Therapeutic Modalities for Metastatic Pancreatic Cancer;Korean Journal of Pancreas and Biliary Tract;2016-10-30

3. Hybrid Video Transmission Scheme for Minimizing Server Bandwidth Consumption with Zero Start-up Delay in Video-on-Demand Service;IEEE Communications Letters;2012-01

4. A Reverse-Order Scheduling Scheme for Broadcasting Continuous Multimedia Data Over a Single Channel;IEEE Transactions on Broadcasting;2011-09

5. RF Watermark Backward Compatibility Tests for the ATSC Terrestrial DTV Receivers;IEEE Transactions on Broadcasting;2011-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3